Connect with us

Health

Region reports four more deaths, 22 new cases of COVID-19 – KitchenerToday.com

Published

on


Region of Waterloo Public Health is reporting four more deaths related to the coronavirus.

Two of those have been linked to Trinity Village long-term care, where there’s still an active outbreak, which is one of 12 in region.

Pinehaven long-term care has been added to the list, as a staff member there has come down with the virus.

There have now been 72 deaths in the region related to COVID-19.

Outbreaks have also been declared over in the medicine unit at Grand River Hospital, as well as the 3rd floor and 6th floor unit at St. Mary’s General Hospital.

Meantime, 22 new cases were reported on Friday morning, raising the total to 773, with 316 now resolved.

New on Friday as well, the region is now showing a breakdown of cases of the three cities and the four townships on its dashboard.

Kitchener has the most non-facility and facility outbreak cases out of all the area municipalities.

You can find the entire breakdown on the region’s website.

But the acting medical officer of health cautions the results are skewed due to the fact that only prioritized groups and settings are being tested now.

“I think that limitation to testing needs to be take into account … I think what it does show though … it is in all area municipalities, and I think that is the key message for people to be aware of. That people can get it anywhere in Waterloo Region, and there isn’t an area municipality that isn’t at risk,” said Dr. Hsiu-Li Wang.

With warmer weather in the forecast this weekend, regional officials are also reminding residents the emergency measures imposed by the province remain in place.

The region’s CAO says if residents do go out, they should stay as close to home as possible.

“That’s what we would hope to see … people only going out when needed, and if they go out staying as close to home as possible. Avoiding congregating in large groups, avoiding crowded spaces, those type of things,” said Mike Murray.

So far, six fines have been issued for those not following the rules.

Below is a breakdown of the provincial COVID-19 numbers reported on Friday:

  • 16,608 (421 new cases)
  • 10,825
  • 1,121 deaths

Let’s block ads! (Why?)



Source link

Continue Reading

Health

UPDATE: No new cases in Guelph, Wellington County for second straight day – GuelphToday

Published

on


For the second consecutive day there have been no new COVID-19 cases confirmed by Wellington-Dufferin-Guelph Public Health in Guelph and Wellington County.

The numbers of cases and the number of those resolved cases remained the same.

Guelph (cases/deaths): 150/9

Wellington County (cases/deaths): 70/2

Guelph resolved: 111

Wellington County resolved: 48

Hospitalized: 7

Intensive care unit: 2

Let’s block ads! (Why?)



Source link

Continue Reading

Health

'No benefit' from hydroxychloroquine for virus: U.K. trial – CTV News

Published

on


A major British clinical trial has found hydroxychloroquine has “no benefit” for patients hospitalised with COVID-19, scientists said Friday, in the first large-scale study to provide results for a drug at the centre of political and scientific controversy.

Hydroxychloroquine, a decades-old malaria and rheumatoid arthritis drug, has been touted as a possible treatment for the new coronavirus by high profile figures, including U.S. President Donald Trump, and has been included in several randomised clinical trials.

The University of Oxford’s Recovery trial, the biggest of these so far to come forward with findings, said that it would now stop recruiting patients to be given hydroxychloroquine “with immediate effect”. 

“Our conclusion is that this treatment does not reduce the risk of dying from COVID among hospital patients and that clearly has a significant importance for the way patients are treated, not only in the UK, but all around the world,” said Martin Landray, an Oxford professor of medicine and epidemiology who co-leads the study. 

The randomised clinical trial — considered the gold standard for clinical investigation — has recruited a total of 11,000 patients from 175 hospitals in the UK to test a range of potential treatments. 

Other drugs continuing to be tested include: the combination of HIV antivirals Lopinavir and Ritonavir; a low dose of the steroid Dexamethasone, typically used to reduce inflammation; antibiotic Azithromycin; and the anti inflammatory drug Tocilizumab.

Researchers are also testing convalescent plasma from the blood of people who have recovered from COVID-19, which contains antibodies to fight the virus.

Researchers said 1,542 patients were randomly assigned to hydroxychloroquine and compared with 3,132 patients given standard hospital care alone. 

They found “no significant difference” in mortality after 28 days between the two groups, and no evidence that treatment with the drug shortens the amount of time spent in hospital.

“This is a really important result, at last providing unequivocal evidence that hydroxychloroquine is of no value in treatment of patients hospitalised with COVID-19,” said Peter Openshaw, a professor at Imperial College London, in reaction to the results.

He added that the drug was “quite toxic” so halting the trials would be of benefit to patients.  

Hydroxychloroquine has been in use for years but it has a number of potentially serious side effects, including heart arrhythmia. 

‘IT DOESN’T WORK’

Researchers from the Recovery trial said they would share their data with the World Health Organization (WHO), which on Wednesday restarted its own trials of hydroxychloroquine.

They were temporarily halted last month because of a now-retracted observational study in The Lancet medical journal that had suggested hydroxychloroquine and chloroquine, a related compound, were ineffective against COVID-19 and even increased the risk of death.

Authors of the Lancet research said on Thursday that they could no longer vouch for the integrity of its underlying data, in the face of serious concerns raised by fellow scientists over a lack of clarity about the countries and hospitals that contributed patient information.   

The scandal cast a shadow over The Lancet and another top medical journal, but it did nothing to clear up the increasingly politicised question of whether or not hydroxychloroquine works as a treatment for COVID-19. 

Openshaw said the Recovery trial should be credited with continuing the research until they could reach a definitive conclusion on hydroxychloroquine. 

“Everyone regrets that it doesn’t work, but knowing that allows us to focus on finding drugs that actually help recovery from COVID-19,” he added. 

Oxford professor Peter Horby, the lead investigator on the Recovery Trial, said there was probably a “very large number” of people around the world taking hydroxychloroquine for COVID-19, with countries including the U.S., China and Brazil authorising it. 

A separate clinical trial on Wednesday in the U.S. and Canada found that taking hydroxychloroquine shortly after being exposed to COVID-19 does not work to prevent infection significantly better than a placebo.

Let’s block ads! (Why?)



Source link

Continue Reading

Health

City asking people to wear masks on buses, but not mandatory – GuelphToday

Published

on


As the city prepares to allow more riders on Guelph Transit buses, it is asking riders to wear a non-medical mask or face covering.

They are not mandatory.

Free 30-minute Guelph Transit service will continue for the rest of June but the city says thta with more businesses reopening and more people heading back to work, Guelph Transit is preparing to resume fare collection and regular schedules later in the summer.

In a news release Friday morning, the city said the request is based advice from Wellington-Dufferin-Guelph Public Health.

“According to health officials, wearing a homemade face covering/non-medical mask is not a substitute for physical distancing and hand washing. Wearing a mask has not been proven to protect the person wearing it, but it can help protect others around you,” the release said.

“As the buses get busy again, physical distancing may not always be possible. We’re asking riders to wear a non-medical mask or face covering to help prevent the spread of COVID-19,” says Robin Gerus, general manager of Guelph Transit.

Guelph Transit is encouraging face coverings, not requiring them.

“It’s becoming more common to wear a mask on public transit in other cities, but it’s new for Guelph. Some riders may not be aware of or understand the latest guidelines from health officials. Some may not have resources to purchase or make a mask, or they may have a medical reason for not wearing one,” added Gerus. Everyone is welcome to use Guelph Transit, and we’re asking people to protect and respect each other as ridership increases.”

Since March, Guelph Transit made the following adjustments to slow the spread of COVID-19:

  • free 30-minute service allows passengers to avoid using the farebox and board from the rear door
  • plastic barrier between the driver and passengers
  • hand sanitizing stations and cleaning supplies for drivers
  • no more than 10 people per bus
  • blocked several seats to encourage physical distancing between passengers

To prevent the spread of COVID-19, the City and Guelph Transit encourage riders to continue following the latest advice from Wellington-Dufferin-Guelph Public Health:

  • wash your hands regularly or use hand sanitizer
  • stay at least two metres away from people you don’t live with
  • when you can’t maintain physical distancing, wear a non-medical mask or face covering

Let’s block ads! (Why?)



Source link

Continue Reading

Trending